spacer
home > pmps > summer 2019 > redefining supply
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Redefining Supply

Passive packaging is coming of age. In a world where door-to-door delivery is transforming the consumer experience, more and more sectors are waking up to the possibilities of delivering temperature-controlled products in a simple, cost-effective, and reliable way.

As the world faces the challenges of global warming, new approaches to packaging also provide opportunities to reassess the impact of supply chains on the planet. However, while industries such as retail and food have been quick to adopt new forms of delivery, they do so without the strict regulations and restraints that often apply to the pharmaceutical sector.

As Managing Director of a company that has invested millions in R&D for passive packaging solutions, I am well aware of both the challenges and benefits they can bring to pharma customers, and, as a passionate believer in the properties of natural materials, I appreciate the particular challenges a more ecological packaging approach presents to this most scientific of sectors.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Josie Morris BA (Hons), MA, is Managing Director at The Wool Packaging Company Ltd (Woolcool). A passionate advocate for diversity and the development of strong cultures within innovative businesses, Josie is also closely involved with organisations such as the Bio-Based Industries Association (BBIA), which lobby the UK government on the environmental problems of global packaging waste and support pioneering companies such as Woolcool that offer genuinely sustainable alternatives to plastic materials.
spacer
josie@woolcool.com
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck Introduces New Integrated Plug & Play Upstream Development Service

Adaptive approach to cell line development, analytics and clone selection for emerging biotechs and start-up Tailored upstream development from a single source reduces time to clinic by 20 percent Fast-track process reduces timeline by 10 weeks for first pharmacodynamic experiment
More info >>

White Papers

Conveying Medical Guidance in Clinical Trials A Survey

Europital Medical Consultancy

With the incremental demand for proactive safety surveillance throughout the conduct of clinical trials, the role of Medical Management is at the fore in ensuring the safety and wellbeing of the participants. The complex responsibilities of a Medical Monitor (MM) starts from the design and development phase, through to study close out. Understanding the principle behind the protocol and the prospective medical solution the study would deliver forms the bloodline for the MM role. Often, the MM is the face of contact for both the site personnel and the study team members with regard to medical, safety and scientific issues within the project. When it comes to medical guidance, the communication channel used to deliver solutions contributes to a large extent in effectively managing decisive situations. Our previous study on acquiring medical guidance from an operations team perspective revealed that e-mails were the most used communication method (see the article, 'Talking Points', in ICT November 2014). In our efforts to further strengthen the mode of medical guidance delivery, we designed a survey to study the existing trend and constraints in this communication chain management, as outlined here.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement